Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry

Show other versions (1)

Bibliographic Details
Main Authors:	Armin Abadeh, Sarah Shehadeh, Stephen Betschel, Susan Waserman, Donald William Cameron, Juthaporn Cowan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653498/?tool=EBI

Similar Items

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
by: Armin Abadeh, et al.
Published: (2023-01-01)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency.
by: Tri Dinh, et al.
Published: (2019-01-01)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.
by: Francesco Cinetto, et al.
Published: (2021-01-01)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
by: Parwinder K. Gill, et al.
Published: (2018-08-01)

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
by: Juthaporn Cowan, et al.
Published: (2015-01-01)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)

ADVERSE EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH ANTIBODY DEFICIENCY
by: A. Aghamohammadi, et al.
Published: (2003-09-01)

Levels of immunoglobulin isotypes in serum and respiratory samples of patients with chronic obstructive pulmonary disease: protocol for a systematic review and meta-analysis
by: Beverley Shea, et al.
Published: (2023-02-01)

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry
by: Martin Stangel, et al.
Published: (2016-05-01)

Cutaquig<sup>®</sup> Is Well Tolerated in Immunodeficient Patients Who Did Not Tolerate Other Subcutaneous Immunoglobulin Products
by: Sydney Brownlee, et al.
Published: (2022-11-01)

Functionality of Immunoglobulin G and Immunoglobulin M Antibody Physisorbed on Cellulosic Films
by: Ziwei Huang, et al.
Published: (2017-07-01)

Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study
by: Paul K. Keith, et al.
Published: (2022-08-01)

Refractory epilepsy: treatment by immunoglobulin
by: Abram Topczewski
Published: (2005-12-01)

Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study
by: Paul K. Keith, et al.
Published: (2023-06-01)

Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
by: J. Bousquet, et al.
Published: (2008-04-01)

The clinical significance of immunoglobulin A deficiency
by: Abdul Latiff, Amir Hamzah, et al.
Published: (2007)

Idiotype-specific intravenous immunoglobulin for therapy of immunoglobulin kappa free light chain deficiency
by: Adina Elena Stanciu, et al.
Published: (2019-05-01)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
by: Andy Ka Chun Kan, et al.
Published: (2022-12-01)

Rubella antibodies in Australian immunoglobulin products
by: Megan K. Young, et al.
Published: (2017-08-01)

Intravenous immunoglobulin for the treatment of childhood encephalitis
by: Iro, M, et al.
Published: (2017)

Immunoglobulin replacement therapy in secondary hypogammaglobulinemia
by: Nicolò eCompagno, et al.
Published: (2014-12-01)

Association of serum immunoglobulin M and immunoglobulin G antibody levels with different indicators of metabolic syndrome
by: Manali Sinharay, et al.
Published: (2023-11-01)

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach
by: Jolles, S, et al.
Published: (2016)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
by: Andrea Visentin, et al.
Published: (2022-12-01)

Successful discontinuation of immunoglobulin G replacement at age 10 in a patient with immunoglobulin G2 deficiency
by: Masayoshi Shinjoh, et al.
Published: (2017-10-01)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
by: Per Wågström, et al.
Published: (2022-01-01)

Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report
by: Houda Ajmi, et al.
Published: (2017-11-01)

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
by: Gastón J Piñeiro, et al.
Published: (2018-10-01)

Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin
by: Mark Reglinski, et al.
Published: (2019-04-01)

PRODUCTION OF MONOCLONAL ANTIBODY AGAINST HUMAN IMMUNOGLOBULIN
by: J. Majidi, et al.
Published: (2000-04-01)

Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases
by: Yuliya V. Markina, et al.
Published: (2020-07-01)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
by: Gemma Grau, et al.
Published: (2019-10-01)

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
by: Jønch Aia, et al.
Published: (2012-09-01)

Perspective of personalized treatment of immunoglobulin A-nephropathy
by: K.S. Komissarov
Published: (2020-02-01)

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations
by: Juthaporn Cowan, et al.
Published: (2018-08-01)

Skin Manifestations in Patients with Selective Immunoglobulin E Deficiency
by: César Picado, et al.
Published: (2022-11-01)

Hay-wells syndrome with selective immunoglobulin a deficiency
by: Bhupathi Sharanya, et al.
Published: (2020-01-01)

Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01)

Protective anti‐prion antibodies in human immunoglobulin repertoires
by: Assunta Senatore, et al.
Published: (2020-09-01)